Screening and identification of T helper 1 and linear immunodominant antibody-binding epitopes in spike 1 domain and membrane protein of feline infectious peritonitis virus

Vaccine

Volumn 32, Issue 16, 2014, Pages 1834-1840

  Takano, Tomomi ^a   Morioka, Hiroyuki ^a   Gomi, Kohji ^a   Tomizawa, Keisuke ^a   Doki, Tomoyoshi ^a   Hohdatsu, Tsutomu ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

Coronavirus; Feline infectious peritonitis; Peptide based vaccine; Th1

Indexed keywords

ANTIGEN; CPG OLIGODEOXYNUCLEOTIDE; EPITOPE; GUANINE NUCLEOTIDE BINDING PROTEIN; M PROTEIN; MEMBRANE PROTEIN; S1 PROTEIN; STRUCTURAL PROTEIN; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; VIRUS PROTEIN; VITRONECTIN;

ANIMAL EXPERIMENT; ANTIGEN BINDING; ARTICLE; CAT; CONTROLLED STUDY; CORONAVIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; SCREENING TEST; SEROTYPE; TH1 CELL;

CORONAVIRUS; FELINE INFECTIOUS PERITONITIS; PEPTIDE-BASED VACCINE; TH1;

ADJUVANTS, IMMUNOLOGIC; AMINO ACID SEQUENCE; ANIMALS; BINDING SITES, ANTIBODY; CATS; CORONAVIRUS, FELINE; FEMALE; IMMUNODOMINANT EPITOPES; LIPOSOMES; MALE; MOLECULAR SEQUENCE DATA; OLIGODEOXYRIBONUCLEOTIDES; SPIKE GLYCOPROTEIN, CORONAVIRUS; TH1 CELLS; VACCINES, SUBUNIT; VIRAL MATRIX PROTEINS;

EID: 84895870798     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.01.074     Document Type: Article

References (30)

1. Pedersen N.C. A review of feline infectious peritonitis virus infection: 1963-2008. J Feline Med Surg 2009, 11:225-258.
2. Motokawa K., Hohdatsu T., Aizawa C., Koyama H., Hashimoto H. Molecular cloning and sequence determination of the peplomer protein gene of feline infectious peritonitis virus type I. Arch Virol 1995, 140:469-480.
3. Motokawa K., Hohdatsu T., Hashimoto H., Koyama H. Comparison of the amino acid sequence and phylogenetic analysis of the peplomer, integral membrane and nucleocapsid proteins of feline, canine and porcine coronaviruses. Microbiol Immunol 1996, 40:425-433.
4. Woods R.D., Pedersen N.C. Cross-protection studies between feline infectious peritonitis and porcine transmissible gastroenteritis viruses. Vet Microbiol 1979, 4:11-16.
5. Pedersen N.C., Boyle J.F., Floyd K., Fudge A., Barker J. An enteric coronavirus infection of cats and its relationship to feline infectious peritonitis. Am J Vet Res 1981, 42:368-377.
6. Pedersen N.C., Black J.W. Attempted immunization of cats against feline infectious peritonitis, using a virulent live virus or sublethal amounts of virulent virus. Am J Vet Res 1983, 44:229-234.
7. Pedersen N.C., Evermann J.F., Mckeirnan A.J., Ott R.L. Pathogenicity studies of feline coronavirus isolates 79-1146 and 79-1683. Am J Vet Res 1984, 45:2580-2585.
8. Barlough J.E., Stoddart C.A., Sorresso G.P., Jacobson R.H., Scott F.W. Experimental inoculation of cats with canine coronavirus and subsequent challenge with feline infectious peritonitis virus. Lab Anim Sci 1984, 34:592-597.
9. Stoddart C.A., Barlough J.E., Baldwin C.A., Scott F.W. Attempted immunisation of cats against feline infectious peritonitis using canine coronavirus. Res Vet Sci 1988, 45:383-388.
10. Pedersen N.C., Boyle J.F. Immunologic phenomena in the effusive form of feline infectious peritonitis. Am J Vet Res 1980, 41:868-876.
11. Weiss R.C., Scott F.W. Antibody-mediated enhancement of disease in feline infectious peritonitis: comparisons with dengue hemorrhagic fever. Comp Immunol Microbiol Infect Dis 1981, 4:175-189.
12. Wang Y.D., Sin W.Y., Xu G.B., Yang H.H., Wong T.Y., Pang X.W., et al. T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus spike protein elicit a specific T-cell immune response in patients who recover from SARS. J Virol 2004, 78:5612-5618.
13. + T cells to severe acute respiratory syndrome (SARS) coronavirus in recovered SARS patients and healthy individuals. J Immunol 2005, 175:591-598.
14. Peng H., Yang L.T., Wang L.Y., Li J., Huang J., Lu Z.Q., et al. Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS recovered patients. Virology 2006, 351:466-475.
15. Tsao Y.P., Lin J.Y., Jan J.T., Leng C.H., Chu C.C., Yang Y.C., et al. HLA-A*0201 T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus nucleocapsid and spike proteins. Biochem Biophys Res Commun 2006, 344:63-71.
16. Yang L.T., Peng H., Zhu Z.L., Li G., Huang Z.T., Zhao Z.X., et al. Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients. Clin Immunol 2006, 120:171-178.
17. Zhou M., Xu D., Li X., Li H., Shan M., Tang J., et al. Screening and identification of severe acute respiratory syndrome-associated coronavirus-specific CTL epitopes. J Immunol 2006, 177:2138-2145.
18. Peng H., Yang L.T., Li J., Lu Z.Q., Wang L.Y., Koup R.A., et al. Human memory T cell responses to SARS-CoV E protein. Microbes Infect 2006, 8:2424-2431.
19. Satoh R., Furukawa T., Kotake M., Takano T., Motokawa K., Gemma T., et al. Screening and identification of T helper 1 and linear immunodominant antibody-binding epitopes in the spike 2 domain and the nucleocapsid protein of feline infectious peritonitis virus. Vaccine 2011, 29:1791-1800.
20. Satoh R., Kaku A., Satomura M., Kohori M., Noura K., Furukawa T., et al. Development of monoclonal antibodies (MAbs) to feline interferon (fIFN)-γ as tools to evaluate cellular immune responses to feline infectious peritonitis virus (FIPV). J Feline Med Surg 2011, 13:427-435.
21. Weiss R.C., Cox N.R. Delayed-type hypersensitivity skin response associated with feline infectious peritonitis in two cats. Res Vet Sci 1988, 44:396-398.
22. Weiss R.C., Cox N.R. Evaluation of immunity to feline infectious peritonitis in cats with cutaneous viral-induced delayed hypersensitivity. Vet Immunol Immunopathol 1989, 21:293-309.
23. Kiss I., Poland A.M., Pedersen N.C. Disease outcome and cytokine responses in cats immunized with an avirulent feline infectious peritonitis virus (FIPV)- UCD1 and challenge-exposed with virulent FIPV-UCD8. J Feline Med Surg 2004, 6:89-97.
24. Gelain M.E., Meli M., Paltrinieri S. Whole blood cytokine profiles in cats infected by feline coronavirus and healthy non-FCoV infected specific pathogen-free cats. J Feline Med Surg 2006, 8:389-399.
25. Bosch B.J., van der Zee R., de Haan C.A., Rottier P.J. The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J Virol 2003, 77:8801-8811.
26. Satoh R., Kotake M., Takano T., Motokawa K., Gemma T., Watanabe R., et al. Identification of cytosine-phosphorothioate-guanine oligodeoxynucleotide sequences that induce interferon-γ production in feline immune cells. Microbiol Immunol 2011, 55(Mar (3)):184-190.
27. Aichele P., Brduscha-Riem K., Oehen S., Odermatt B., Zinkernagel R.M., Hengartner H., et al. Peptide antigen treatment of naive and virus-immune mice: antigen-specific tolerance versus immunopathology. Immunity 1997, 6:519-529.
28. Miconnet I., Koenig S., Speiser D., Krieg A., Guillaume P., Cerottini J.C., et al. CpG are efficient adjuvants for specific CTL induction against tumor antigen-derived peptide. J Immunol 2002, 168:1212-1218.
29. + T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909. J Clin Invest 2005, 115:739-746.
30. Takano T., Tomizawa K., Morioka H., Doki T., Hohdatsu T. Evaluation of protective efficacy of the synthetic peptide vaccine containing the T helper 1 epitope with CpG oligodeoxynucleotide against feline infectious peritonitis virus infection in cats. Antiviral Ther 2014, [in press]. 10.3851/IMP2735.